These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 24517927

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
    Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Lüthi U, Barberis A, Benjamin LE, Mäkinen T, Nobes CD, Adams RH.
    Nature; 2010 May 27; 465(7297):483-6. PubMed ID: 20445537
    [Abstract] [Full Text] [Related]

  • 23. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
    Pfaff D, Héroult M, Riedel M, Reiss Y, Kirmse R, Ludwig T, Korff T, Hecker M, Augustin HG.
    J Cell Sci; 2008 Nov 15; 121(Pt 22):3842-50. PubMed ID: 18957513
    [Abstract] [Full Text] [Related]

  • 24. Preponderance of cells with stem cell characteristics in metastasising mouse mammary tumours induced by deregulated EphB4 and ephrin-B2 expression.
    Kaenel P, Schwab C, Mülchi K, Wotzkow C, Andres AC.
    Int J Oncol; 2011 Jan 15; 38(1):151-60. PubMed ID: 21109936
    [Abstract] [Full Text] [Related]

  • 25. Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.
    Das A, Shergill U, Thakur L, Sinha S, Urrutia R, Mukhopadhyay D, Shah VH.
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun 15; 298(6):G908-15. PubMed ID: 20338920
    [Abstract] [Full Text] [Related]

  • 26. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
    Kim I, Ryu YS, Kwak HJ, Ahn SY, Oh JL, Yancopoulos GD, Gale NW, Koh GY.
    FASEB J; 2002 Jul 15; 16(9):1126-8. PubMed ID: 12039842
    [Abstract] [Full Text] [Related]

  • 27. EphB4 overexpression in B16 melanoma cells affects arterial-venous patterning in tumor angiogenesis.
    Huang X, Yamada Y, Kidoya H, Naito H, Nagahama Y, Kong L, Katoh SY, Li WL, Ueno M, Takakura N.
    Cancer Res; 2007 Oct 15; 67(20):9800-8. PubMed ID: 17942910
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.
    Erber R, Eichelsbacher U, Powajbo V, Korn T, Djonov V, Lin J, Hammes HP, Grobholz R, Ullrich A, Vajkoczy P.
    EMBO J; 2006 Feb 08; 25(3):628-41. PubMed ID: 16424904
    [Abstract] [Full Text] [Related]

  • 31. Immunohistochemical study in dural arteriovenous fistula and possible role of ephrin-B2 for development of dural arteriovenous fistula.
    Tirakotai W, Bian LG, Bertalanffy H, Siegfried B, Sure U.
    Chin Med J (Engl); 2004 Dec 08; 117(12):1815-20. PubMed ID: 15603710
    [Abstract] [Full Text] [Related]

  • 32. Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells.
    Hamada K, Oike Y, Ito Y, Maekawa H, Miyata K, Shimomura T, Suda T.
    Arterioscler Thromb Vasc Biol; 2003 Feb 01; 23(2):190-7. PubMed ID: 12588758
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy.
    Davies MH, Stempel AJ, Hubert KE, Powers MR.
    Dev Dyn; 2010 Jun 01; 239(6):1695-707. PubMed ID: 20503366
    [Abstract] [Full Text] [Related]

  • 35. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO, Davies MH, Planck SR, Rosenbaum JT, Powers MR.
    Invest Ophthalmol Vis Sci; 2005 Jun 01; 46(6):2175-82. PubMed ID: 15914639
    [Abstract] [Full Text] [Related]

  • 36. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy.
    Ehlken C, Martin G, Lange C, Gogaki EG, Fiedler U, Schaffner F, Hansen LL, Augustin HG, Agostini HT.
    Acta Ophthalmol; 2011 Feb 01; 89(1):82-90. PubMed ID: 19764912
    [Abstract] [Full Text] [Related]

  • 37. The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis.
    Martiny-Baron G, Holzer P, Billy E, Schnell C, Brueggen J, Ferretti M, Schmiedeberg N, Wood JM, Furet P, Imbach P.
    Angiogenesis; 2010 Sep 01; 13(3):259-67. PubMed ID: 20803239
    [Abstract] [Full Text] [Related]

  • 38. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization.
    Shin D, Garcia-Cardena G, Hayashi S, Gerety S, Asahara T, Stavrakis G, Isner J, Folkman J, Gimbrone MA, Anderson DJ.
    Dev Biol; 2001 Feb 15; 230(2):139-50. PubMed ID: 11161568
    [Abstract] [Full Text] [Related]

  • 39. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells.
    Foubert P, Silvestre JS, Souttou B, Barateau V, Martin C, Ebrahimian TG, Leré-Déan C, Contreres JO, Sulpice E, Levy BI, Plouët J, Tobelem G, Le Ricousse-Roussanne S.
    J Clin Invest; 2007 Jun 15; 117(6):1527-37. PubMed ID: 17510705
    [Abstract] [Full Text] [Related]

  • 40. Hypoxia inducible factor-1alpha and expression of vascular endothelial growth factor and its receptors in cerebral arteriovenous malformations.
    Ng I, Tan WL, Ng PY, Lim J.
    J Clin Neurosci; 2005 Sep 15; 12(7):794-9. PubMed ID: 16165361
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.